PMID- 22521847 OWN - NLM STAT- MEDLINE DCOM- 20120920 LR - 20120528 IS - 1873-2518 (Electronic) IS - 0264-410X (Linking) VI - 30 IP - 27 DP - 2012 Jun 8 TI - Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition. PG - 4079-85 LID - 10.1016/j.vaccine.2012.04.022 [doi] AB - Porcine circovirus associated disease (PCVAD) encompasses a group of syndromes linked to infection with porcine circovirus type 2 (PCV2). Based on the hypothesis that the immune responses to vaccination versus infection are quantitatively and qualitatively different, the objective of this study was to evaluate immunity, virus replication and disease protection in pigs vaccinated with PCV2 capsid protein (CP) and during infection. The disease model included dual infection with PCV2 and porcine reproductive and respiratory syndrome virus (PRRSV), a virus known to enhance disease progression and severity. The principal effect of PRRSV infection was to increase peak PCV2 viremia by almost 40-fold; however, PCV2 failed to show a reciprocal effect on PRRSV. In vaccinated pigs, there was no evidence of disease or PCV2 replication following dual virus challenge. Immunity following vaccination favored PCV2 neutralizing activity; whereas, PCV2 infection and disease produced high levels of non-neutralizing antibody, primarily directed against a polypeptide in the C-terminal region of CP. These results support the notion that the magnitude of the total antibody response cannot be used as a measure of protective immunity. Furthermore, protection versus disease lies in the immunodominance of specific epitopes. Epitope specificity should be taken into consideration when designing PCV2 vaccines. CI - Copyright (c) 2012 Elsevier Ltd. All rights reserved. FAU - Trible, Benjamin R AU - Trible BR AD - Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, 1800 Denison Ave, Kansas State University, Manhattan, KS 66506, USA. FAU - Ramirez, Alejandro AU - Ramirez A FAU - Suddith, Andrew AU - Suddith A FAU - Fuller, Alexandra AU - Fuller A FAU - Kerrigan, Maureen AU - Kerrigan M FAU - Hesse, Richard AU - Hesse R FAU - Nietfeld, Jerome AU - Nietfeld J FAU - Guo, Baoqing AU - Guo B FAU - Thacker, Eileen AU - Thacker E FAU - Rowland, Raymond R R AU - Rowland RR LA - eng SI - GENBANK/JQ692110 PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20120419 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (Antibodies, Neutralizing) RN - 0 (Antibodies, Viral) RN - 0 (Epitopes) RN - 0 (Viral Vaccines) SB - IM MH - Animals MH - Antibodies, Neutralizing/*blood MH - Antibodies, Viral/*blood MH - Circoviridae Infections/*immunology/virology MH - Circovirus/classification/genetics/*immunology MH - Coinfection/immunology/virology MH - Disease Models, Animal MH - Epitopes/immunology MH - Molecular Sequence Data MH - Porcine respiratory and reproductive syndrome virus/pathogenicity MH - Sequence Analysis, DNA MH - Swine MH - Viral Load MH - Viral Vaccines/administration & dosage/*immunology MH - Viremia/diagnosis/virology EDAT- 2012/04/24 06:00 MHDA- 2012/09/21 06:00 CRDT- 2012/04/24 06:00 PHST- 2011/12/17 00:00 [received] PHST- 2012/03/13 00:00 [revised] PHST- 2012/04/03 00:00 [accepted] PHST- 2012/04/24 06:00 [entrez] PHST- 2012/04/24 06:00 [pubmed] PHST- 2012/09/21 06:00 [medline] AID - S0264-410X(12)00544-0 [pii] AID - 10.1016/j.vaccine.2012.04.022 [doi] PST - ppublish SO - Vaccine. 2012 Jun 8;30(27):4079-85. doi: 10.1016/j.vaccine.2012.04.022. Epub 2012 Apr 19.